Euflexxa vs Monovisc – Knee Treatment Comparison

Last Updated On: September 10, 2024

Maintaining smooth joint movement relies on a delicate balance of lubrication and shock absorption. This interplay is essential for navigating daily activities comfortably and reducing wear and tear. Viscosupplements support this balance by acting as lubricants and shock absorbers.

Euflexxa and Monovisc are popular viscosupplements designed to alleviate knee pain. They both work by providing additional lubrication and cushioning, which helps improve mobility and relieve discomfort. Each option can extend pain relief for up to six months, making them effective choices for managing osteoarthritis.

This article will delve into the specifics of Euflexxa and Monovisc, exploring their mechanisms, efficacy, potential side effects, and cost-effectiveness.

Key Takeaways

• Euflexxa and Monovisc are used to treat knee osteoarthritis by acting like a cushion in the knee, but they have different ingredients and treatment plans. Euflexxa needs three shots over several weeks, while Monovisc just one.
• Clinical trials show that both treatments can reduce pain and improve mobility with positive patient feedback. Most patients report less pain and better movement after these treatments.
• The cost of treatment varies, with Euflexxa ranging from $600 – $1,200 for the full course and Monovisc from $500 – $1,000. Insurance often covers them, but out-of-pocket costs can differ based on the number of injections needed.
• The duration of relief from both treatments is similar, lasting up to six months, depending on individual patient responses. This long-lasting effect helps improve the quality of life for knee osteoarthritis patients.

About: Operating since 2016, Med Supply Solutions is known for being one of the industry’s top and trusted suppliers of cosmetic and viscosupplementation products. Buy Euflexxa at Med Supply Solutions today and stock your practice at wholesale prices!

Introduction to Euflexxa and Monovisc

Euflexxa and Monovisc are advanced viscosupplements designed to treat knee osteoarthritis by enhancing joint lubrication and cushioning. Euflexxa, composed of a refined form of hyaluronic acid, and Monovisc, featuring a highly pure form of hyaluronic acid, aim to alleviate pain and improve mobility in affected knees.

While Euflexxa requires a series of three injections, Monovisc is administered in a single dose. Understanding these differences helps tailor treatment to individual patient needs, providing effective relief and improving quality of life.

Composition and Mechanism of Action

In Euflexxa and Monovisc, the main ingredient acts like a cushion in your knee. This helps your knee move smoothly and reduces pain.

Euflexxa

Euflexxa, a refined hyaluronic acid, mimics natural knee lubricant, easing pain and improving mobility for osteoarthritis patients. Free from animal proteins, it’s suitable for those with allergies. Administered in several injections, it enhances joint lubrication and function. This approach offers a safe, effective alternative, with Euflexxa prescribing information aiding informed treatment decisions.

Monovisc

Monovisc, a pure hyaluronic acid derived via fermentation, is a lubricant and shock absorber for the knee. Its single-shot treatment simplifies the process, providing relief with just one injection. This approach restores natural hyaluronan balance, improving knee function and reducing osteoarthritis pain. Monovisc offers an efficient solution for managing knee pain by delaying the need for invasive treatments.

Clinical Efficacy

To see which knee treatment works best, we look at how well Euflexxa and Monovisc help people. Studies show that pain decreases and knees move better after these treatments.

Clinical Trials and Expert Reviews on Euflexxa

Clinical trials reveal that Euflexxa provides substantial pain relief, with patients experiencing improved mobility and reduced discomfort. Notably, early treatment with Euflexxa yields better outcomes, emphasizing its effectiveness in enhancing patient well-being.

Similarly, Euflexxa’s safety profile is well-established. It exhibits minimal adverse effects, making it a reliable choice for practitioners. Patients appreciate its ease of administration and long-lasting benefits. As a valuable addition to the armamentarium against knee OA, Euflexxa empowers healthcare professionals to optimize patient care and improve quality of life.

Clinical Trials and Expert Reviews on Monovisc

In a pivotal phase III clinical trial, Monovisc demonstrated early and durable pain relief following a single intra-articular injection. Patients experienced improved joint function and reduced discomfort, making it an attractive option for practitioners seeking effective OA treatment.

Monovisc’s safety profile is favorable, and its single-dose administration simplifies patient care. With promising results in alleviating knee pain, Monovisc empowers healthcare professionals to enhance quality of life for individuals with OA. As a reliable choice, Monovisc plays a crucial role in managing knee OA symptoms.

Practical Considerations

Practical considerations explore how each treatment fits into a patient’s life, from how often they need shots to what it might cost. 

Treatment Protocols for Euflexxa and Monovisc

Adhering to treatment protocols helps deliver medication accurately, minimize risks, and enhance patient outcomes by providing consistent pain relief and improved mobility.

• Eligibility Assessment: Evaluate knee osteoarthritis severity and patient history for Euflexxa and knee pain history for Monovisc.
• Pre-Treatment Preparation: Review Euflexxa prescribing information and clean the knee area while scheduling and cleaning the knee for Monovisc.
• Anesthesia: Euflexxa typically does not require local anesthesia, whereas Monovisc may use it to minimize discomfort.
• Injection Procedure: Administer three Euflexxa injections a week apart using ultrasound guidance and a single Monovisc injection with ultrasound guidance if available.
• Post-Injection Monitoring: Observe patients for reactions and provide aftercare instructions for Euflexxa. Monitor and instruct on activity restrictions for Monovisc.
• Follow-Up: Schedule follow-up appointments to assess response and plan further management for Euflexxa, and to evaluate efficacy and discuss next steps for Monovisc.
• Patient Education: Inform Euflexxa patients about possible side effects and reporting procedures while advising Monovisc patients on potential side effects and when to seek medical attention.

Patient Satisfaction with Euflexxa and Monovisc

Patients with knee osteoarthritis often find Euflexxa effective. They experience reduced pain and improved mobility, with high satisfaction and minimal side effects. At the same time, Monovisc receives positive feedback for its single-injection convenience, offering significant relief and quick improvements. Doctors highly recommend both treatments for effectively managing knee osteoarthritis.

Cost Comparison

Euflexxa and Monovisc vary in cost, with Euflexxa typically requiring multiple injections, which can increase the total expense. Monovisc, with its single-injection approach, often proves more cost-effective overall. While individual prices may differ, Monovisc’s one-time treatment may offer a more affordable option than the cumulative costs of Euflexxa.

Duration of Relief Provided by Euflexxa and Monovisc

Euflexxa provides knee osteoarthritis relief for up to six months by lubricating the joint, reducing pain, and improving mobility. Patients often experience significant improvement after three injections over several weeks, making movement easier.

Monovisc also offers up to six months of relief with a single injection. This convenient treatment improves pain and mobility, supporting better daily function and quality of life. Doctors note its effectiveness and patient satisfaction, making it a popular choice for managing knee osteoarthritis.

Conclusion

Picking between Euflexxa and Monovisc for knee treatment can be tricky. Both have their perks in easing knee pain from osteoarthritis. Studies show each works well, but patient feedback and costs might sway your choice. Think about what matters most for your health and budget. Talking to a doctor helps narrow it down, ensuring you get the right help for your knees.

FAQs

1. What is Euflexxa, and how does it compare to Monovisc for knee treatment?

Euflexxa (sodium hyaluronate) and Monovisc are viscosupplements for knee pain relief in osteoarthritis, each offering different benefits.

2. How does Euflexxa differ from similar treatments like Supartz or Hyalgan? 

Euflexxa, Supartz, and Hyalgan are hyaluronic acid injections with varying formulations, effectiveness, and side effect profiles.

3. Is one treatment superior to the others among Euflexxa, Supartz, and Hyalgan? 

Effectiveness varies by individual, so discussing options with a healthcare provider is crucial to finding the best treatment.

4. Can I switch between these treatments if one does not work effectively? 

You can switch treatments if one is ineffective; consult your healthcare provider for suitable alternatives.

References

Vaienti E, Scita G, Ceccarelli F, Pogliacomi F. Understanding the human knee and its relationship to total knee replacement. Acta Bio Medica : Atenei Parmensis. 2017;88(Suppl 2):6-16. doi:https://doi.org/10.23750/abm.v88i2-S.6507 

How Do I Increase My Synovial Fluid? Verywell Health. https://www.verywellhealth.com/how-to-increase-synovial-fluid-5114374